-
Most Commented
- Cubadebate opens its new Web page in English | 20
- Mandela is dead: Why hide the truth about Apartheid? | 11
- El Paso Diary: The Battle Over the Solo Fax | 10
- President Hugo Chavez's address to the People of Venezuela | 10
- Free the Five is heard at Left Forum | 6
- May every citizen be a constituent | 6
- Raúl receives Kim Yong Chol, Special Envoy of the President of the Workers’ Party of Korea | 6
- The Unsustainable Position of the Empire | 5
- U.S. government promoting Internet aggression against Cuba | 5
- NATO’s Genocidal Role | 4
- The Fiftieth Anniversary Parade | 4
- El Paso Diary: The Tip of the Iceberg | 4
Series
- Cuba's Reasons
- Cuban Five
- El Paso Diary
The El Paso Diary is written by José Pertierra--an attorney who represents the government of Venezuela in its request for the extradition of Luis Posada Carriles. Pertierra´s journals describe the testimony, evidence, legal skirmishes, quirks and follies of this very historic trial that features for the first time the close collaboration of the United States government with Cuban authorities to prosecute an ex CIA agent who is one of the masterminds of the fifty-year old dirty war against Cuba.
Authors
- Bernie Dwyer
- Bruno Rodríguez Parrilla
- Deisy Francis Mexidor
- Fidel Castro Ruz
- José Pertierra
- Raúl Castro Ruz
- Ricardo Alarcón de Quesada
- Amy Goodman
- Arleen Rodríguez Derivet
- Frei Betto
- Hugo Chávez Frías
- Josh R. Nelson
- Juan Gelman
- Luis Rumbaut
- Michael Moore
- Mumia Abu-Jamal
- Noam Chomsky
- Reinaldo Taladrid Herrero
- Richard Gott
- Tom Hayden
Articles of vaccine
News »
Abdala vaccine clinical trial is going well in Cuba
Abdala vaccine clinical trial is going well in CubaSantiago de Cuba, Jan 9 (Prensa Latina) The clinical trial of the vaccine candidate Abdala, one of the four underway in Cuba, is going well today at the Saturnino Lora Hospital in this eastern city, where it has been taking place for the last month. Dr. Rafael Suárez, director of the healthcare center, reported that the intramuscular application of the preparation for immunization against Covid-19 has hardly presented adverse reactions, mainly associated with discomfort in the area of the puncture.
News »
Cuba and Iran sign an agreement on Sovereign vaccine 02
Cuban Finlay Vaccines Institute and the Pasteur Institute of Iran signed a collaboration agreement here to complement the clinical evidence of the anti-Covid-19 vaccine candidate from the Caribbean island, Soberana02. In its official Twitter account, the Cuban entity explained that ‘this synergy will allow faster progress in immunization against the SARS-CoV-2 virus in both countries.’
News »
The freedom conquered in 1959 continues to illuminate the country
Fidel continues to command his rebel armies in a Freedom Caravan that has traveled across Cuba every January since 1959, making clear that the memory of that transcendental event in the country’s history continues to inspire new victories in the many battles Cubans face. The new “Caravanistas” from Santiago de Cuba initiated their journey, that will culminate on January 8, in Havana, from the city’s Avenida de los Libertadores, alongside the former Moncada Garrison, which became the July 26 Educational Center following the triumph of the Revolution.
News »
New horizons for science and innovation
Armando Rodríguez Batista, Deputy Minister of Science, Technology and Environment (Citma), explained to Granma that these norms were the first of a much more comprehensive legal package which continues to be presented (Decree 2/2020 on Advanced Technology Enterprises, Decree Law 7/2020 and its complementary provisions), to guide implementation of policies to perfect Cuba’s science, technology and innovation system, approved by the Council of Ministers in October of 2018.
News »
Clinical trials of Mambisa and Abdala candidate vaccines approved
After a careful review of the information presented, including evidence from pharmaceutical development and studies in animals, the Center for the State Control of Drugs, Equipment and Medical Devices (Cecmed), authorized the clinical trials of two new Cuban candidate vaccines to prevent COVID-19, given the names of Mambisa (CIGB-669) and Abdala (CIGB-66). Trials of the first, created by researchers at the Genetic Engineering and Biotechnology Center (CIGB), affiliated with the BioCubaFarma Enterprise Group
News »
Cuba presents another COVID-19 candidate vaccine
Biotechnology made in Cuba shows its strengths once again. The Center for Genetic Engineering and Biotechnology (CIGB) has submitted the technical file of their first vaccine candidate against COVID-19 to the State Center for the Control of Medicines, Medical Equipment and Devices (CECMED).
News »
Political Bureau discusses issues to be addressed during 8th Congress of the Communist Party of Cuba
Chaired by its first secretary, Army General Raul Castro Ruz, the Political Bureau of the Communist Party of Cuba Central Committee met yesterday to address issues that will be presented for analysis at the upcoming 8th Congress of the organization. On this occasion, analyzed was the document entitled “Assessment of policies regarding Party cadres, the Young Communists League, mass organizations, the state and government. Role of the Party to achieve superior results.”
News »
The emergence of Soberana 1 is not a chance event
Since the beginning of the Revolution, the priority granted to scientific progress, with emphasis on the training of highly qualified human capital and the creation of research centers in dissimilar branches of knowledge, were essential prerequisites that allowed Cuba to venture into the promising sector of biotechnology in the decade of the 1980s, practically at the same time this industry was emerging in a small group of nations with greater technological development.
News »
BioCen develops secure medium to transport viral samples, a first in Cuba
Researchers at the National Biopreparations Center (BioCen) have developed Cuba’s first secure medium to transport viruses, created for use in the collection and transfer of patients’ nasopharyngeal and oropharyngeal samples for the diagnosis of SARS-COV-2, the COVID-19 causal agent. BioCen achieved and industrially scaled the product in only seven days and, subsequently received its Sanitary Registration from the State Center for the Control of Drugs, Equipment and Medical Devices (Cecmed).
News »
Second group of volunteers join Soberana clinical trials
Twenty more Cubans joined the short history of Soberana 01, the country’s first candidate vaccine against COVID-19, on September 2, according to reports from Naturaleza Secreta. This group, composed of volunteers between 60 and 80 years of age, is the second to receive the first dose of the much awaited vaccine.